<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:40:33" record="21113" source="Espacenet">
	<entities>
		<entity ref="Patent21113" type="Patent">
			<semanticIdentifier>brcris::61314cfe0c8622bec95593cfcdc56bc6</semanticIdentifier>
			<semanticIdentifier>docdb::BR102019004434A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102019004434</semanticIdentifier>
			<semanticIdentifier>docdb::BR102019004434A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20191004434</semanticIdentifier>
			<semanticIdentifier>original::102019004434</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102019004434"/>
			<field name="identifier.lattes" value="4550946765956962"/>
			<field name="identifier.espacenet" value="102019004434"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="usos terapêuticos do alpha-terpineol para o tratamento das doenças cardiovasculares"/>
			<field name="title.lattes" value="Usos terapêuticos do alpha-terpineol para o tratamento das doenças cardiovasculares"/>
			<field name="depositDate" value="2019-03-07"/>
			<field name="publicationDate" value="2020-10-06"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="ALDEIDIA PEREIRA DE OLIVEIRA"/>
			<field name="inventor" value="ALESSANDRO CESAR BERNARDINO"/>
			<field name="inventor" value="AMANDA KARINE BARROS FERREIRA RODRIGUES"/>
			<field name="inventor" value="EDEILDO FERREIRA JUNIOR"/>
			<field name="inventor" value="EMANUEL TENORIO PAULINO"/>
			<field name="inventor" value="EURICA ADELIA NOGUEIRA RIBEIRO"/>
			<field name="inventor" value="JESSYKA CAROLINA GALVAO"/>
			<field name="inventor" value="KELLY RAYANE VITAL OLIVEIRA"/>
			<field name="inventor" value="LUCINDO JOSE QUINTANS JUNIOR"/>
			<field name="inventor" value="MARIA LUIZA DAL PONT"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DE ALAGOAS"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K31/045AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="045AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61P3/06AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="3"/>
				<field name="subgroup" value="06AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61P9/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61P9/02AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="02AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="A61P9/06AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="06AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="6"/>
				<field name="text" value="A61P9/08AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="08AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="7"/>
				<field name="text" value="A61P9/10AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="10AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="8"/>
				<field name="text" value="A61P9/12AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="12AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="9"/>
				<field name="text" value="A61P9/14AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="14AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="10"/>
				<field name="text" value="C07C33/14AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="C"/>
				<field name="group" value="33"/>
				<field name="subgroup" value="14AI"/>
			</field>
			<field name="abstract.espacenet" value="usos terapêuticos do alpha-terpineol para o tratamento das doenças cardiovasculares as doenças cardiovasculares (dc &#769;s) ocupam o primeiro lugar em óbitos no mundo, devido à injúria por anóxia. a complexidade da farmacoterapia das dc &#769;s associada à inexistencia de fármacos cardioprotetores incentiva o desenvolvimento de estratégias de cardioproteção. assim, a-terpineol (tpn) é um monoterpeno que exibe ações vasorelaxante, mas não cardioprotetora. este trabalho objetivou-se em avaliar a cardioproteção do tpn nas lesões cardíacas. para isto ratos foram alocados em 6 grupos e tratados por 15 dias por via oral, em seguida induzidos ao infarto: (g1= salina 0,9%); (g2= infartado salina 0,9%); (g3=tpn 25 mg/kg); (g4=tpn 50 mg/kg); (g5=tnp 75 mg/kg) e (g6=tpn 50 mg/kg sem iso). no 16º os animais foram anestesiados e foram realizados ensaios bioquímicos, morfométricos, hemodinâmicos, reatividade baroreflexa e eletrocardiográficos. os resultados mostraram que tpn aumentou a sobrevivência dos animais ao infarto induzido, reduziu a área de necrose no miocárdio, preveniu as alterações eletrocardiográficas e inibiu a liberação de marcadores cardíacos, além disso, tpn inibiu a elevação da frequência cardíaca induzida por isoproterenol. adicionalmente, tpn produziu dilatação coronariana e neovascularização endotelial em aortas de ratos. tpn induziu bradicardia intravenosa e seus mecanismos envolvem receptores m2 cardíacos e o bloqueio sobre os vocc &#769;s. conclui-se que o tpn produz cardioproteção."/>
			<field name="originatesFrom" value="73015749"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102019004434"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102019004434"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102019004434"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20191004434"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102019004434"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person14638" type="Person">
			<semanticIdentifier>lattes::4550946765956962</semanticIdentifier>
			<field name="identifier.lattes" value="4550946765956962"/>
			<field name="name" value="Jessyka Carolina Galvão da Silva"/>
		</entity>
		<entity ref="OrgUnit11496" type="OrgUnit">
			<semanticIdentifier>brcris::7da810a4b15bbe1fe6be6e8254160456</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE FEDERAL DE ALAGOAS"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent21113" toEntityRef="Person14638" type="Inventor"/>
		<relation fromEntityRef="Patent21113" toEntityRef="OrgUnit11496" type="Applicant"/>
	</relations>
</entity-relation-data>
